Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 48, 2020 - Issue 1
Submit an article Journal homepage
2,322
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Improving radio-chemotherapy efficacy of prostate cancer by co-deliverying docetaxel and dbait with biodegradable nanoparticles

Nianli Liua Cancer Institute of Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Jiayin Jib Department of Internal Medicine, NO.731 Hospital of CASIC, Beijing, ChinaView further author information
,
Hui Qiuc Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Zhiying Shaod Department of Interventional Ultrasound, Zhejiang Cancer Hospital, Hangzhou, ChinaView further author information
,
Xin Wenc Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Aoxing Chenc Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Senbang Yaoc Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Xingying Zhangc Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Hong Yaoa Cancer Institute of Xuzhou Medical University, Xuzhou, China;e Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou, ChinaCorrespondence[email protected]
View further author information
&
Longzhen Zhanga Cancer Institute of Xuzhou Medical University, Xuzhou, China;c Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China;e Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 305-314 | Received 29 Jun 2019, Accepted 19 Oct 2019, Published online: 20 Dec 2019

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.
  • Yap TA, Smith AD, Ferraldeschi R, et al. Drug discovery in advanced prostate cancer: translating biology into therapy. Nat Rev Drug Discov. 2016;15(10):699–718.
  • Pal SK, Sartor O. Prostate cancer: the best fit for enzalutamide in metastatic prostate cancer. Nat Rev Clin Oncol. 2014;11(9):504–506.
  • Robinson D, Van Allen EM, Wu YM, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;161(5):1215–1228.
  • Quanz M, Berthault N, Roulin C, et al. Small-molecule drugs mimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy. Clin Cancer Res. 2009;15(4):1308–1316.
  • Quanz M, Chassoux D, Berthault N, et al. Hyperactivation of DNA-PK by double-strand break mimicking molecules disorganizes DNA damage response. PLoS One. 2009;4(7):e6298.
  • Coquery N, Pannetier N, Farion R, et al. Distribution and radiosensitizing effect of cholesterol-coupled Dbait molecule in rat model of glioblastoma. PLoS One. 2012;7(7):e40567.
  • Yao H, Qiu H, Shao Z, et al. Nanoparticle formulation of small DNA molecules, Dbait, improves the sensitivity of hormone-independent prostate cancer to radiotherapy. Nanomedicine. 2016;12(8):2261–2271.
  • Herath NI, Devun F, Lienafa MC, et al. The DNA repair inhibitor DT01 as a novel therapeutic strategy for chemosensitization of colorectal liver metastasis. Mol Cancer Ther. 2016;15(1):15–22.
  • Yao H, Ng SS, Tucker WO, et al. The gene transfection efficiency of a folate-PEI600-cyclodextrin nanopolymer. Biomaterials. 2009;30(29):5793–5803.
  • Xia W, Low PS. Folate-targeted therapies for cancer. J Med Chem. 2010;53(19):6811–6824.
  • Rotow J, Gameiro SR, Madan RA, et al. Vaccines as monotherapy and in combination therapy for prostate cancer. Clin Transl Sci. 2010;3(3):116–122.
  • Hema S, Thambiraj S, Shankaran DR. Nanoformulations for targeted drug delivery to prostate cancer: an overview. J Nanosci Nanotechnol. 2018;18(8):5171–5191.
  • Prabhakar U, Maeda H, Jain RK, et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res. 2013;73(8):2412–2417.
  • Zhang X, Liu N, Shao Z, et al. Folate-targeted nanoparticle delivery of androgen receptor shRNA enhances the sensitivity of hormone-independent prostate cancer to radiotherapy. Nanomedicine. 2017;13(4):1309–1321.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.